BioSpace News Archive

Business

InVivo Therapeutics Reports 2018 Third Quarter Financial Results and Provides Business Update

- Announces Western Institutional Review Board Approval for Select INSPIRE 2.0 Study Sites -

November 8, 2018
·
6 min read
Phonak Honored for ‘Accessibility’ and ‘3D Printing’ with Two CES 2019 Innovation Awards

Phonak Audéo™ Marvel and Phonak Virto™ B-Titanium both named CES 2019 Innovation Awards Honorees

November 8, 2018
·
5 min read
Business

vTv Therapeutics Announces Third Quarter 2018 Results and Update

vTv Therapeutics Inc. today reported financial results for the third quarter that ended September 30, 2018, and provided an update on recent achievements and upcoming events.

November 8, 2018
·
12 min read
Pharm Country

Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)

Sandoz Inc. is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level.

November 8, 2018
·
6 min read
Job Trends

New Solution for Distance and Astigmatism Vision Correction with the Visian Toric ICL

New treatment available at KE Eye Centers of Texas

November 8, 2018
·
3 min read
Job Trends

Apple’s Face ID Security Available in Mobile App for Clinical Trial Management

Crucial Data Solutions announces the latest update to their native mobile app for clinical trial data collection and management. TrialKit™, an eClinical platform, has incorporated Apple’s biometric technologies for user authentication

November 8, 2018
·
3 min read
Drug Development

NextCure to Present Preclinical Data on NC318, a Novel Immunomedicine Targeting Siglec-15, at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

NextCure, Inc. today announced that preclinical data supporting the development of its lead drug candidate, NC318, will be presented in a poster session at the Society for Immunotherapy of Cancer 33rd Annual Meeting being held November 7th – 11th 2018 in Washington, D.C.

November 8, 2018
·
2 min read
Deals

BioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company

BioTime Acquires Two Clinical-Stage Cell Therapy Product Candidates Addressing Significant Unmet Needs in Spinal Cord Injury and Immuno-Oncology

November 8, 2018
·
13 min read
Policy

Mallinckrodt Earns International Standard ISO 13485:2016 and Medical Device Single Audit Program (MDSAP) Certifications for INOmax® DSIR® Plus Nitric Oxide Delivery Systems

Achievements Indicate Mallinckrodt Meets Standards and Regulations Among the Most Comprehensive for Medical Device Quality Management Systems

November 8, 2018
·
10 min read
Drug Development

Evofem Biosciences Completes Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy

Company Remains on Track for AMPOWER Top-line Results in Late 2018

November 8, 2018
·
7 min read